Since our last wildly successful equity crowdfunding campaign closed in November 2020, we’ve been super busy at PKA SoftTouch Corp.
If you follow us or invest in our internationally patented microneedle technology, you’ll recall that last fall we soared past our most recent crowdfunding goal by 175% raising $437,000. Those investment dollars are paying for all the groundwork needed for our upcoming veterinary clinical trials at the University of Guelph, Ontario. Once those trials are complete, we expect to see veterinary pharmaceutical companies stepping in to license our technology, leading to a preliminary revenue stream.
Another Chance to Invest
And no, you haven’t missed out on this groundbreaking opportunity! Our next equity crowdfunding raise gives you a chance to participate in the vast and growing injectable drug and vaccine market, valued at $369 billion in 2017 with growth projected to $779 billion by 2024. Our hot news is that we will soon begin the campaign for $500,000 to finance those human clinical trials, complemented by a further raise of $700,000 from accredited investors, for a total of $1.2 million.
We will keep you posted as we move closer to the launch date when, once again, you can invest for a minimum of $500 on the well-known FrontFundr platform.
In the meantime, if you are one of our 435 large and small investors, you know a couple of things already: You’ll know the ethical and financial elegance of investing in this medical technology. You get the chance to turn a tidy profit on your investment and to also bring a life-saving disposable and painless drug injection device to the world marketplace at the same time.
At a time when it couldn’t be needed more! From a socially responsible investment perspective, it doesn’t get much better.
At PKA SoftTouch, we know it can be hard to be patient with the process, and medical device investors are often prepared to wait ten years before they see a return on their investment. We expect to have money flowing into your pockets well before that.
Testing right on track
We’re right on track to move to our veterinary clinical trials. Part 1 of this two-stepped process, using easily modified 3-D technology for our medical devices, is slated for the mid-May. The second and final part of the veterinary trials takes place in December. By then we will have tweaked and refined our device technology by curating moulds to the point of perfection and complete reliability and lower costs.
A key asset in this entire process is PKA founder Dick Crawford’s skillset and extensive background as a project engineer for large pharmaceutical builds. Dick knows how to co-ordinate, plan and project-manage with the very best and keeps all the bits and pieces flowing in harmony.
So watch this space – we have lots to tell you in the upcoming weeks as we get ready for our next equity crowdfunding launch!